Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06759389 · ClinicalTrials.gov registry record · NA
The VENTOR Clinical Study
A NA study of Cardiac Arrest (CA), sponsored by CoLabs Medical.
- Recruiting
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT06759389: Recruiting NA study of Cardiac Arrest (CA), sponsored by CoLabs Medical.
NCT06759389 is a NA study of Cardiac Arrest (CA) that is actively recruiting participants, run by CoLabs Medical. The registered enrollment target is 25 participants, below the 558-participant average among 3 other Cardiac Arrest (CA) trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06759389, a NA study of Cardiac Arrest (CA), is actively recruiting participants, sponsored by CoLabs Medical.
- RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
To evaluate the initial safety and effectiveness of the Ventor Airway System in providing short-term ventilation support in non-breathing subjects during cardiopulmonary resuscitation (CPR) and respiratory arrests.
Primary Outcome
As measured through the monitoring of intra-arrest PaO2
Conditions Studied
Interventions
- DEVICE Resuscitation (Ventor)
Study Locations (1)
New York
- Stony Brook University Hospital - Stony Brook
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2025-04-04 |
| Est. Completion | 2026-06 |
| Phase | NA |
What NCT06759389 shows while recruiting
NCT06759389 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 558-participant average among 3 other Cardiac Arrest (CA) trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Cardiac Arrest (CA) appearing as the primary indexed condition, and to 1 intervention - of which Resuscitation (Ventor) is the first listed.
NCT06759389 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06759389 about?
NCT06759389 is a clinical study titled "The VENTOR Clinical Study". To evaluate the initial safety and effectiveness of the Ventor Airway System in providing short-term ventilation support in non-breathing subjects during cardiopulmonary resuscitation (CPR) and respiratory arrests.
What is the current status of trial NCT06759389?
This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2025-04-04. Estimated completion is 2026-06.
What conditions does trial NCT06759389 study?
This clinical trial studies the following conditions: Cardiac Arrest (CA).
What interventions are being tested in trial NCT06759389?
The interventions under investigation include: Resuscitation (Ventor) (DEVICE).
Who is sponsoring clinical trial NCT06759389?
This trial is sponsored by CoLabs Medical, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06759389 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiac Arrest (CA)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI